Brief: CLS, Toronto General Hospital Resume Clinical Trial For Prostate Cancer As Co Receives Approval For Updated Sterilization Process By Health Canada
12/07/2021 12:06
July 12 (Reuters) - Clinical Laserthermia Systems AB
CLSRb.ST :
* CLS, TORONTO GENERAL HOSPITAL RESUME CLINICAL TRIAL FOR
PROSTATE
CANCER AS CO RECEIVES APPROVAL FOR UPDATED STERILIZATION PROCESS
BY HEALTH CANADA
Source text for Eikon: ID:nGNX3tm7Mc
Further company coverage: CLSRb.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clinical Laserthermia Systems AB
See all newsBrief: Clinical Laserthermia Systems AB Resolves On A Directed Issue
Brief: Clinical Laserthermia Appoints Katarina Lundqvist As Permanent CFO
Brief: CLS Announces Outcome In Rights Issue Of Units
Brief: CLS Agrees On Top-Down Guarantee For Rights Issue
Brief: CLS Conducts Rights Issue Of SEK 39.5 Million